Bactericidal activity of BMY-28100 versus amoxicillin/clavulanic acid againstBranhamella catarrhalis

  • E. Yourassowsky
  • M. P. Van der Linden
  • M. J. Lismont
  • F. Crokaert
New Antimicrobial Agents
  • 14 Downloads

Keywords

Internal Medicine Bactericidal Activity 

References

  1. 1.
    Amsterdam, D., Jones, R. N. In vitro technical commentBranhamella catarrhalis assessing beta-lactamase production. Antimicrobial Newsletter 1985, 2: 79–90.Google Scholar
  2. 2.
    Calder, M. A., Croughan, M. J., McLeod, D. T., Ahmad, F. The incidence and antibiotic susceptibility ofBranhamella catarrhalis in respiratory infections in 1986. Drugs, 1987, 31, Supplement 3: 12–16.Google Scholar
  3. 3.
    Aldridge, K. E., Shiro, D. D., Sanders, C. V. Comparative in vitro activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 170–172.PubMedGoogle Scholar
  4. 4.
    Kayser, F. H. Comparative antibacterial activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 309–312.PubMedGoogle Scholar
  5. 5.
    Leitner, Felix, Pursiano, T. A., Buck, R. E., Tsai, Y. H., Chisholm, D. R., Misiek, M., Desiderio, J. V., Kessler, R. E. BMY-28100, a new oral cephalosporin. Antimicrobial Agents and Chemotherapy 1987, 31: 238–243.PubMedGoogle Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1988

Authors and Affiliations

  • E. Yourassowsky
    • 1
  • M. P. Van der Linden
    • 1
  • M. J. Lismont
    • 1
  • F. Crokaert
    • 1
  1. 1.Department of MicrobiologyBrugman University HospitalBrusselsBelgium

Personalised recommendations